A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories

Clinical Chemistry

Volumn 55, Issue 9, 2009, Pages 1701-1710

  Caliendo, Angela M ^a,b,e   Shahbazian, Mona D ^c   Schaper, Carl ^d   Ingersoll, Jessica ^a,b   Abdul Ali, Deborah ^a,b   Boonyaratanakornkit, Jerry ^c   Pang, Xiao Li ^e   Fox, Julie ^e   Preiksaitis, Jutta ^e   Schönbrunner, E Ralf ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CENTER FOR AIDS RESEARCH   (United States)

^c AcroMetrix Corporation   (United States)

^d Provincial Laboratory for Public Health ^*

^e EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALIBRATION; CALIBRATOR; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EXTRACTION; FOOD AND DRUG ADMINISTRATION; HUMAN; LABORATORY; NONHUMAN; QUANTITATIVE ANALYSIS; STANDARDIZATION; VIRUS DETECTION; VIRUS LOAD;

CALIBRATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; VIRAL LOAD;

CYTOMEGALOVIRUS;

EID: 69549092206     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.124743     Document Type: Article

References (20)

1. Humar A, Gregson D, Caliendo AM, McGeer A, Malkan G, Krajden M, et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999;68:1305-1311
2. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000;355:2032-2036 (Pubitemid 30339241)
3. Sia IG, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 2000;13:83-121. (Pubitemid 30039345)
4. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002;186:829-833 (Pubitemid 35013436)
5. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK, for the American Society of Transplantation Infectious Diseases Community of Practice and the Canadian Society of Transplantation. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009;9:258-268
6. Mori T, Okamoto S, Watanabe R, Yajima T, Iwao Y, Yamazaki R, et al. Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;29:777-782 (Pubitemid 34618910)
7. Ikewaki J, Ohtsuka E, Satou T, Kawano R, Ogata M, Kikuchi H, Nasu M. Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;35:403-410 (Pubitemid 40309487)
8. Posfay-Barbe KM. Optimal approach to prevent CMV disease. Pediatr Transplant 2008;12:385-388
9. Armbruster D, Miller RR. The Joint Committee for Traceability in Laboratory Medicine (JCTLM): a global approach to promote the standardisation of clinical laboratory test results. Clin Biochem Rev 2007;28:105-114
10. International Organization for Standardization. ISO 17511:2003. In vitro diagnostic medical devices - measurement of quantities in biological samples - metrological traceability of values assigned to calibrators and control materials. Geneva: International Organization for Standardization; 2003.
11. Miller WG, Myers GL, Rej R. Why commutability matters. Clin Chem 2006;52:553-554
12. Cattozzo G, Franzini C, Melzi d'Eril GM. Commutability of calibration and control materials for serum lipase. Clin Chem 2001;47:2108-2113
13. Vesper HW, Miller WG, Myers GL. Reference materials and commutability. Clin Biochem Rev 2007;28:139-147
14. Brion E, Lessinger JM, Gould N, Leyendecker J, Ferard G. Evaluation of commutability of control materials. Clin Chem Lab Med 2002;40:625-630
15. Cobbaert C, Weykamp C, Baadenhuijsen H, Kuypers A, Lindemans J, Jansen R. Selection, preparation, and characterization of commutable frozen human serum pools as potential secondary reference materials for lipid and apolipoprotein measurements: study within the framework of the Dutch project "Calibration 2000." Clin Chem 2002;48:1526-1538 (Pubitemid 34925788)
16. Pang XL, Chui L, Fenton J, LeBlanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS Amplicor CMV Monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol 2003;41:3167-3174 (Pubitemid 36842317)
17. Schaade L, Kockelkorn P, Ritter K, Kleines M. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J Clin Microbiol 2000;38:4006-4009 (Pubitemid 32233197)
18. Clinical and Laboratory Standards Institute. CLSI/NCCLS approved guideline EP14-A2. Evaluation of matrix effects. Wayne (PA): Clinical and Laboratory Standards Institute; 2005.
19. Clinical and Laboratory Standards Institute. CLSI/NCCLS proposed guideline C53-P. Characterization and qualification of commutable reference materials for laboratory medicine. Wayne (PA): Clinical and Laboratory Standards Institute; 2008.
20. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310 (Pubitemid 16134762)